1-186314718-C-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 3P and 2B. PM2PP2BP4_Moderate
The NM_003292.3(TPR):c.6947G>A(p.Ser2316Asn) variant causes a missense change. The variant allele was found at a frequency of 0.0000449 in 1,603,942 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000079 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000041 ( 0 hom. )
Consequence
TPR
NM_003292.3 missense
NM_003292.3 missense
Scores
2
7
10
Clinical Significance
Conservation
PhyloP100: 5.37
Genes affected
TPR (HGNC:12017): (translocated promoter region, nuclear basket protein) This gene encodes a large coiled-coil protein that forms intranuclear filaments attached to the inner surface of nuclear pore complexes (NPCs). The protein directly interacts with several components of the NPC. It is required for the nuclear export of mRNAs and some proteins. Oncogenic fusions of the 5' end of this gene with several different kinase genes occur in some neoplasias. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 1 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), TPR. . Gene score misZ 2.9916 (greater than the threshold 3.09). Trascript score misZ 3.9792 (greater than threshold 3.09). GenCC has associacion of gene with intellectual developmental disorder, autosomal recessive 79.
BP4
Computational evidence support a benign effect (MetaRNN=0.20096242).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TPR | NM_003292.3 | c.6947G>A | p.Ser2316Asn | missense_variant | 50/51 | ENST00000367478.9 | NP_003283.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TPR | ENST00000367478.9 | c.6947G>A | p.Ser2316Asn | missense_variant | 50/51 | 1 | NM_003292.3 | ENSP00000356448 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000790 AC: 12AN: 151886Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
12
AN:
151886
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000451 AC: 11AN: 243952Hom.: 0 AF XY: 0.0000605 AC XY: 8AN XY: 132254
GnomAD3 exomes
AF:
AC:
11
AN:
243952
Hom.:
AF XY:
AC XY:
8
AN XY:
132254
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000413 AC: 60AN: 1452056Hom.: 0 Cov.: 28 AF XY: 0.0000471 AC XY: 34AN XY: 722310
GnomAD4 exome
AF:
AC:
60
AN:
1452056
Hom.:
Cov.:
28
AF XY:
AC XY:
34
AN XY:
722310
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000790 AC: 12AN: 151886Hom.: 0 Cov.: 32 AF XY: 0.0000944 AC XY: 7AN XY: 74158
GnomAD4 genome
AF:
AC:
12
AN:
151886
Hom.:
Cov.:
32
AF XY:
AC XY:
7
AN XY:
74158
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
2
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 20, 2023 | The c.6947G>A (p.S2316N) alteration is located in exon 50 (coding exon 50) of the TPR gene. This alteration results from a G to A substitution at nucleotide position 6947, causing the serine (S) at amino acid position 2316 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D
M_CAP
Benign
D
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationAssessor
Benign
L
MutationTaster
Benign
D
PrimateAI
Uncertain
T
PROVEAN
Benign
N
REVEL
Benign
Sift
Pathogenic
D
Sift4G
Uncertain
D
Polyphen
D
Vest4
MutPred
Loss of phosphorylation at S2316 (P = 0.0054);
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at